Preliminary results from FLAGSHP-1: A phase I dose escalation study of ERAS-601, a potent SHP2 inhibitor, in patients with previously treated advanced or metastatic solid tumors Meeting Abstract
| Authors: | McKean, M.; Barve, M.; Hong, D.; Parikh, A.; Rosen, E.; Yang, J.; Picard, R.; Yi, J.; Brail, L.; Vecchio, D.; Meniawy, T.; John, T.; Wang, J. |
| Abstract Title: | Preliminary results from FLAGSHP-1: A phase I dose escalation study of ERAS-601, a potent SHP2 inhibitor, in patients with previously treated advanced or metastatic solid tumors |
| Meeting Title: | 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 174 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Oct 26-28 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S34 |
| Language: | English |
| ACCESSION: | WOS:000876973400081 |
| PROVIDER: | wos |
| DOI: | 10.1016/s0959-8049(22)00890-5 |
| Notes: | Meeting Abstract: 95 (PB085) -- In Poster Session "New Drugs" -- Source: Wos |
